Once the US Food and Drug Administration (FDA) greenlights a new drug or medical device, how doctors talk to their patients about them becomes super important. This chat should cover both the benefits and the risks, especially if the product was approved fast-track with limited data. Also, doctors n
NYC's health plan for city employees recently scrapped coverage for weight loss drugs called GLP-1s. Almost 400, 000 employees are affected, many of whom find these drugs quite effective. But the city says it'll save money by doing this. Interestingly, other chronic diseases like diabetes usually ge
New York City's drugstore landscape has seen a significant shrinkage over the past decade, with about 40% fewer stores compared to ten years ago. This year alone saw a 10% drop, attributed largely to rising shoplifting and crime rates. Major pharmacy chains like Walgreens, CVS, and Rite Aid have bee
Elon Musk, a tech billionaire advising the incoming president, thinks the solution to America's obesity crisis lies in making new weight loss drugs cheap. Meanwhile, Robert F. Kennedy Jr. , the president-elect's pick for health secretary, believes lifestyle changes are key. Both views highlight the
Two key figures in President-elect Donald Trump's circle have differing views on tackling America's obesity crisis. Robert F. Kennedy Jr. , nominated for Secretary of Health and Human Services, favors lifestyle changes as the primary approach. He believes that modifying diet and exercise habits shou
These days, there's a buzz about certain weight-loss drugs like Ozempic, Wegovy, and Zepbound. A recent study by health data company Truveta found that people taking these drugs often end up seeing their doctor more. This isn't just about slimming down; it's also leading to diagnoses of other relate
Did you know that a popular diabetes medicine called Ozempic might be linked to a rare but serious eye condition? Health experts in Europe are digging into this possibility after some recent studies suggested a potential connection. This eye condition, called NAION, can lead to sudden and permanent
Scientists have been working hard to improve targeted drug delivery by using the acidic environment in tumors. They focus on changing the active sites of drugs, like hydroxyl groups, to enhance stability, lower toxicity, and boost how well the drug hits its target. But the problem lies in making the
Ever wondered why some medicines for rare diseases are finally becoming more accessible? Let's break down the factors that are making this happen. First off, the internet and tech advancements have made it easier to find and connect with folks who have rare diseases. Laws in many countries are also
High blood pressure, or hypertension, is a big deal. It's not just about feeling a bit dizzy; it's a significant risk factor for serious stuff like heart disease, kidney problems, and strokes. Shockingly, only 14% of patients in developing countries manage to keep their blood pressure under control.
